Thu, Nov 12, 2026 - Page 25
13819 indexed SquawkNews stories from this UTC day. Showing 2881-3000.
L
Sensus Healthcare 3Q Loss/Shr 9c >SRTS
Sensus Healthcare 3Q Loss/Shr 9c >SRTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
ONCE UPON A FARM PBC Q3 GROSS MARGIN 36.1%
ONCE UPON A FARM PBC Q3 GROSS MARGIN 36.1%
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Vuzix Corporation (VUZI) Q3 Revenue Fell 38% to $0.7M
Vuzix reported Q3 2026 revenue of $0.7M, down 38% from $1.2M a year earlier, and a net loss of $8.4M versus $7.4M. Cash was $9.2M with no debt; operating cash use was $6.7M versus $5.0M.Material DetailsContext by AI Anal
EARNINGS | Nov 12, 2026, 09:05 PM UTC
M
Armata Reports $54.9M Q3 Net Income on $69.6M Loan Fair-Value Gain
Armata reported Q3 2026 net income of $54.9 million, compared with a $26.7 million net loss in Q3 2025. The result was primarily driven by a $69.6 million convertible-loan fair-value gain. Its planned AP-SA02 Phase 3 stu
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
EQUILLIUM Q3 EPS USD -0.04 VS. IBES ESTIMATE USD -0.05
EQUILLIUM Q3 EPS USD -0.04 VS. IBES ESTIMATE USD -0.05
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
SENSUS HEALTHCARE Q3 BASIC EPS USD -0.09
SENSUS HEALTHCARE Q3 BASIC EPS USD -0.09
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
DIGIMARC Q3 OPERATING INCOME USD -8.021 MILLION
DIGIMARC Q3 OPERATING INCOME USD -8.021 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
SPRUCE POWER REPORTS THIRD QUARTER 2026 RESULTS
SPRUCE POWER REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SELLAS LIFE SCIENCES Q3 BASIC EPS USD -0.05
SELLAS LIFE SCIENCES Q3 BASIC EPS USD -0.05
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update
SP001, an anti-CD40L antibody with potential across multiple immune-mediated diseases, advancing tow
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
System1 Announces Third Quarter 2026 Financial Results
Revenue of $26.0 million GAAP Gross Profit of $20.7 million, margin of 80% Adjusted Gross Profit of
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
DIGIMARC Q3 NET INCOME USD -7.937 MILLION
DIGIMARC Q3 NET INCOME USD -7.937 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
Presented positive updated efficacy and pooled safety data on amsoki-cel in advanced melanoma at the
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
*SoundThinking 3Q Loss $8.47M >SSTI
*SoundThinking 3Q Loss $8.47M >SSTI
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SoundThinking 3Q Loss/Shr 64c >SSTI
SoundThinking 3Q Loss/Shr 64c >SSTI
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates — Completed initial
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SOUNDTHINKING, INC. REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
SOUNDTHINKING, INC. REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Fluent 3Q Rev $53.6M >FLNT
Fluent 3Q Rev $53.6M >FLNT
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Rollins to Present at Upcoming Investor Conferences
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Fluent 3Q Loss/Shr 12c >FLNT
Fluent 3Q Loss/Shr 12c >FLNT
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
NeuroPace (NPCE) Q3 Revenue Fell 1.1% To $23.1M
Q3 2026 revenue declined 1.1% to $23.1M from $23.4M a year earlier; non-GAAP operating income was $0.4M versus a $1.4M loss. NeuroPace said revenue was below expectations and reported cash and restricted cash of $49.5M a
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Fluent 3Q Loss $3.13M >FLNT
Fluent 3Q Loss $3.13M >FLNT
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
PEDEVCO REPORTS THIRD QUARTER 2026 RESULTS
PEDEVCO REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Enhanced Group Inc. Reports Third Quarter 2026 Results
Enhanced Group Inc. (NYSE:ENHA) (“Enhanced” or the “Company”), a sports, live entertainment and performance products company, today announced financial results for its third quarter ended September 30, 2026. The results
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
FLUENT ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS; COMMERCE MEDIA SOLUTIONS REVENUE DOUBLES AND ANNUAL RUN RATE NOW EXCEEDS $145 MILLION
FLUENT ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS; COMMERCE MEDIA SOLUTIONS REVENUE DOUBLES AND
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Cisco Reports Q1 EPS of $1.14
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
VIRGIN GALACTIC ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
VIRGIN GALACTIC ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Digimarc 3Q Rev $6.45M >DMRC
Digimarc 3Q Rev $6.45M >DMRC
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
IMMUCELL CORPORATION Q3 PRETAX PROFIT USD 936 THOUSAND
IMMUCELL CORPORATION Q3 PRETAX PROFIT USD 936 THOUSAND
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Digimarc 3Q Loss/Shr 36c >DMRC
Digimarc 3Q Loss/Shr 36c >DMRC
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
VUZIX REPORTS THIRD QUARTER 2026 RESULTS
VUZIX REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
DIGIMARC Q3 PRETAX PROFIT USD -7.9 MILLION
DIGIMARC Q3 PRETAX PROFIT USD -7.9 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Digimarc 3Q Loss $8.09M >DMRC
Digimarc 3Q Loss $8.09M >DMRC
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
EQUILLIUM Q3 OPERATING INCOME USD -5.048 MILLION VS. IBES ESTIMATE USD -6.14 MILLION
EQUILLIUM Q3 OPERATING INCOME USD -5.048 MILLION VS. IBES ESTIMATE USD -6.14 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
VUZIX REPORTS THIRD QUARTER 2026 RESULTS
VUZIX REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
INTRUSION Q3 OPERATING INCOME USD -2.798 MILLION
INTRUSION Q3 OPERATING INCOME USD -2.798 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2026
IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2026
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
IMMUCELL CORPORATION Q3 NET INCOME USD 953 THOUSAND
IMMUCELL CORPORATION Q3 NET INCOME USD 953 THOUSAND
FX | Nov 12, 2026, 09:05 PM UTC
L
HireQuest (HQI) Q3 Revenue Rose 4% to $8.8M; Net Income Fell to $1.7M
Q3 2026 revenue rose 4.0% year over year to $8.8M; pro forma for the MRINetwork Assets Divestiture, revenue rose 11.1%. Net income fell to $1.7M from $2.3M, primarily due to a $1.3M notes-receivable write-down and higher
RATES | Nov 12, 2026, 09:05 PM UTC
L
PEDEVCO CORP Q3 NET INCOME USD -9.242 MILLION
PEDEVCO CORP Q3 NET INCOME USD -9.242 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
Arcadia Biosciences (RKDA) Announces Third Quarter 2026 Financial Results and Business Highlights
- Zola® Q3 revenues increase 24% year-over-year, largest quarterly sales ever -- -- New 1L espresso
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
IMMUCELL CORPORATION Q3 EPS USD 0.1
IMMUCELL CORPORATION Q3 EPS USD 0.1
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Virgin Galactic Announces Third Quarter 2026 Financial Results and Provides Business Update
Virgin Galactic Holdings, Inc. (NYSE:SPCE) (“Virgin Galactic” or the “Company”) today announced its financial results for the third quarter ended September 30, 2026 and provided a business update.“Spaceship Apeiron’s arr
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Intellicheck Reports Third Quarter 2026 Results
Net Income Rises to $0.5 Million Adjusted EBITDA Increases to $0.9 Million Cash Balance Grows to $13
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Once Upon a Farm (OFRM) Q3 Sales Rose 34.9% to $89.1M
Q3 2026 net sales rose 34.9% to $89.1M from $66.0M a year earlier. Gross margin fell to 36.1% from 42.1%, net loss was $3.8M versus $11.3M, and the company updated its 2026 outlook to reflect the Tractor Wheels recall.Ma
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
WidePoint 3Q Loss/Shr 2c >WYY
WidePoint 3Q Loss/Shr 2c >WYY
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SENSUS HEALTHCARE Q3 NET INCOME USD -1.493 MILLION
SENSUS HEALTHCARE Q3 NET INCOME USD -1.493 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
SPRUCE POWER Q3 NET INCOME USD 6.178 MILLION
SPRUCE POWER Q3 NET INCOME USD 6.178 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
Vuzix Reports Third Quarter 2026 Results
ROCHESTER, N.Y., Nov. 12, 2026 // -- Vuzix® Corporation (NASDAQ:VUZI) ("Vuzix" or the "Company"), a supplier of AI-powered smart glasses, waveguides for smart glasses and co-packaged optical data center interconnects, an
EQUITY | Nov 12, 2026, 09:05 PM UTC
H
Grown Rogue Reports Third Quarter 2026 Results
Steady Execution Across Existing and New Markets; 2026 and 2027 Guidance and Growth Targets MaintainedMEDFORD, Ore., Nov. 12, 2026 /CNW/ -- Grown Rogue International Inc. ("Grown Rogue," "we," "us," "our," or the "Compan
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Merlin, Inc. Reports Third Quarter 2026 Results
Merlin, Inc. Reports Third Quarter 2026 Results BOSTON, Nov.
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update
LOS ANGELES, Nov. 12, 2026 // -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Intellicheck 3Q EPS 2c >IDN
Intellicheck 3Q EPS 2c >IDN
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
LEGACY EDUCATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS AND RECORD STUDENT POPULATION
LEGACY EDUCATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS AND RECORD STUDENT POPULATION
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Virgin Galactic 3Q Loss $58.8M >SPCE
Virgin Galactic 3Q Loss $58.8M >SPCE
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
INTRUSION Q3 GROSS PROFIT USD 1.477 MILLION
INTRUSION Q3 GROSS PROFIT USD 1.477 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Virgin Galactic 3Q Loss/Shr 39c >SPCE
Virgin Galactic 3Q Loss/Shr 39c >SPCE
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Flowers Foods 3Q Sales $1.17B >FLO
Flowers Foods 3Q Sales $1.17B >FLO
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SKYX REPORTS RECORD REVENUE OF $25.7M IN Q-3 2026 COMPARED TO $23.9M IN Q-3 2025 AND 11 CONSECUTIVE QUARTERS OF GROWTH YOY
SKYX REPORTS RECORD REVENUE OF $25.7M IN Q-3 2026 COMPARED TO $23.9M IN Q-3 2025 AND 11 CONSECUTIVE
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Flowers Foods 3Q Adj EPS 10c >FLO
Flowers Foods 3Q Adj EPS 10c >FLO
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
SYSTEM1 INC. Q3 GROSS PROFIT USD 20.7 MILLION
SYSTEM1 INC. Q3 GROSS PROFIT USD 20.7 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
Obsidian Therapeutics, Inc. (“Obsidian”) (NASDAQ:OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, t
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Spruce Power Reports Third Quarter 2026 Results
Spruce Power Holding Corporation (NYSE:SPRU) (“Spruce”, "Spruce Power" or the “Company”), a leading owner and operator of distributed solar energy assets across the United States, today reported financial results for the
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SPRUCE POWER Q3 INCOME FROM OPERATIONS USD 8.455 MILLION
SPRUCE POWER Q3 INCOME FROM OPERATIONS USD 8.455 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
CODEXIS Q3 OPERATING INCOME USD -7.436 MILLION
CODEXIS Q3 OPERATING INCOME USD -7.436 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
CAPSOVISION REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
CAPSOVISION REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
H
NEUROPACE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES REVISED FULL YEAR GUIDANCE
NEUROPACE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES REVISED FULL YEAR GUIDANCE
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
SHIMMICK CORP Q3 ADJUSTED NET INCOME USD 4 MILLION
SHIMMICK CORP Q3 ADJUSTED NET INCOME USD 4 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
SHIMMICK CORP Q3 NET INCOME USD 1 MILLION
SHIMMICK CORP Q3 NET INCOME USD 1 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
BEELINE HOLDINGS INC Q3 NET INCOME USD -3.81 MILLION
BEELINE HOLDINGS INC Q3 NET INCOME USD -3.81 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
LINEAGE CELL THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
LINEAGE CELL THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Digital Realty Declares Quarterly Cash Dividends on Common and Preferred Stock
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update - To
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Digimarc Corporation (DMRC) Q3 Revenue Falls to $6.4M, ARR to $10.8M
Q3 2026 revenue was $6.4M versus $7.6M a year earlier, and ending ARR was $10.8M versus $15.8M. Net loss was $8.1M, or $0.36 per diluted share, compared with $8.2M, or $0.38, a year earlier.Material DetailsContext by AI
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Flowers Foods 3Q EPS 7c >FLO
Flowers Foods 3Q EPS 7c >FLO
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
ARCADIA BIOSCIENCES Q3 EPS USD 0.29
ARCADIA BIOSCIENCES Q3 EPS USD 0.29
EARNINGS | Nov 12, 2026, 09:05 PM UTC
M
System1 Reports Q3 2026 Results Amid Search Monetization Pressure
System1 said Google monetization at Startpage remained under pressure and CouponFollow lost monetizable traffic. The release provided no financial figures.
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
NEUROPACE, INC. Q3 GROSS PROFIT USD 19.471 MILLION
NEUROPACE, INC. Q3 GROSS PROFIT USD 19.471 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
CODEXIS Q3 BASIC EPS USD -0.08
CODEXIS Q3 BASIC EPS USD -0.08
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
SENSUS HEALTHCARE Q3 ADJUSTED EBITDA USD -1.468 MILLION
SENSUS HEALTHCARE Q3 ADJUSTED EBITDA USD -1.468 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
Evommune Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Evommune, Inc. (NYSE:EVMN) (the “Company” or “Evommune”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
SYSTEM1 ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
SYSTEM1 ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Lineage Cell Therapeutics, Inc. (LCTX) Reports $4.2M Q3 Net Income; Acquires NeuroAirmid
Lineage reported Q3 2026 net income of $4.2M versus a $29.8M net loss in Q3 2025, primarily due to non-cash warrant remeasurement. It closed the NeuroAirmid acquisition, adding clinical-stage HUNT1 to its pipeline.Materi
MNA | Nov 12, 2026, 09:05 PM UTC
H
NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance
NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the third quarter ended September 30, 2026, and provided a co
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Cibus Reports Third Quarter Financial Results and Provides Business Update
Cibus Reports Third Quarter Financial Results and Provides Business Update Rice herbicide-tolerance
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
GCT SEMICONDUCTOR HOLDINGS INC Q3 NET INCOME USD -7.388 MILLION
GCT SEMICONDUCTOR HOLDINGS INC Q3 NET INCOME USD -7.388 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
Intellicheck Reports Third Quarter 2026 Results
Intellicheck, Inc. (NASDAQ:IDN) (“Intellicheck” or the “Company”), an industry-leading identity company delivering proprietary on-demand digital and physical identification validation solutions, today reported financial
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
CAPSOVISION INC Q3 PRETAX PROFIT USD -7.339 MILLION
CAPSOVISION INC Q3 PRETAX PROFIT USD -7.339 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
UNITED STATES ANTIMONY Q3 REVENUE USD 10.1 MILLION
UNITED STATES ANTIMONY Q3 REVENUE USD 10.1 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
SPRUCE POWER Q3 REVENUE USD 29.693 MILLION
SPRUCE POWER Q3 REVENUE USD 29.693 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
ARCADIA BIOSCIENCES Q3 NET INCOME USD 1.755 MILLION
ARCADIA BIOSCIENCES Q3 NET INCOME USD 1.755 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
UNITED STATES ANTIMONY Q3 NET INCOME USD -9.5 MILLION
UNITED STATES ANTIMONY Q3 NET INCOME USD -9.5 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
GCT SEMICONDUCTOR HOLDINGS INC Q3 REVENUE USD 1.069 MILLION
GCT SEMICONDUCTOR HOLDINGS INC Q3 REVENUE USD 1.069 MILLION
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
HireQuest Reports Financial Results for Third Quarter 2026
GOOSE CREEK, S.C., Nov. 12, 2026 // -- HireQuest (Nasdaq: HQI), a national franchisor of on-demand staffing and direct-hire recruiting services, today reported financial results for the third quarter ended September 30,
GEOPOLITICS | Nov 12, 2026, 09:05 PM UTC
L
Legacy Education Reports First Quarter Fiscal 2027 Results and Record Student Population
LANCASTER, Calif., Nov. 12, 2026 // -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE American: LGCY), a provider of career education healthcare programs, today announced financial and operating result
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
System1 Announces Intention to Voluntarily Delist From NYSE
System1 said it intends to voluntarily delist its shares from the New York Stock Exchange.
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
EVOMMUNE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
EVOMMUNE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Spero Therapeutics 3Q Loss $44.3M >SPRO
Spero Therapeutics 3Q Loss $44.3M >SPRO
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
NEUROPACE, INC. Q3 EPS USD -0.1
NEUROPACE, INC. Q3 EPS USD -0.1
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
WD-40 to Present at Morgan Stanley Consumer & Retail Conference
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Spero Therapeutics 3Q Loss/Shr 76c >SPRO
Spero Therapeutics 3Q Loss/Shr 76c >SPRO
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Once Upon a Farm Reports Third Quarter 2026 Financial Results
Once Upon a Farm, PBC (NYSE:OFRM) (or the “Company”), a leading high-growth company driving systemic improvement in childhood nutrition, today announced financial results for the third quarter ended September 30, 2026.Th
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Knightscope, Inc. (KSCP) Q3 Revenue Rises 177% Year Over Year to $8.7M
Knightscope reported Q3 2026 revenue of $8.7M, up 177% year over year. It said approximately $27M in renewals, bookings, and client awards secured since May 2026 remain to be converted into revenue.Material DetailsContex
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
Buda Juice Reports Third Quarter 2026 Financial Results
Third Quarter Revenue Grows 64% to Record $5.2 Million Continued Profitability: Pre-Tax Income Rises
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
System1 Announces Third Quarter 2026 Financial Results
System1, Inc. (NYSE:SST) ("System1" or the "Company"), which operates flagship internet utilities including CouponFollow, MapQuest, and Startpage, and a best-in-class customer acquisition and marketing platform powered b
MNA | Nov 12, 2026, 09:05 PM UTC
M
Veeva to Report Fiscal 2027 Third-Quarter Results December 3
Veeva Systems said it will announce its fiscal 2027 third-quarter results on December 3, 2026.
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
INTRUSION Q3 NET INCOME USD -3.082 MILLION
INTRUSION Q3 NET INCOME USD -3.082 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
DIGIMARC Q3 ADJUSTED GROSS MARGIN 82%
DIGIMARC Q3 ADJUSTED GROSS MARGIN 82%
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Buda Juice Reports Third Quarter 2026 Financial Results
Buda Juice, Inc. (NYSE American: BUDA | NYSE Texas: BUDA) (“Buda Juice” or the “Company”), creator and pioneer of the Ultra Fresh™ category in the supermarket fresh produce department, today reported its financial result
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
HireQuest 3Q EPS 12c >HQI
HireQuest 3Q EPS 12c >HQI
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
CODEXIS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
CODEXIS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Lineage Cell Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Lineage Cell Therapeutics, Inc. (NYSE American and TASE:LCTX), a clinical-stage biotechnology company developing novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today reported its third
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
Digimarc Reports Third Quarter 2026 Financial Results
Digimarc Corporation (NASDAQ:DMRC) reported financial results for the third quarter ended September 30, 2026."Last quarter we said our new execution focus was starting to show results. Since then, many of those results m
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
VUZIX Q3 SALES USD 714 THOUSAND
VUZIX Q3 SALES USD 714 THOUSAND
FX | Nov 12, 2026, 09:05 PM UTC
L
CIBUS REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
CIBUS REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:05 PM UTC
L
NEWSMAX INC Q3 ADJUSTED EBITDA USD 19 MILLION
NEWSMAX INC Q3 ADJUSTED EBITDA USD 19 MILLION
FX | Nov 12, 2026, 09:05 PM UTC
L
GCT Semiconductor Holding (GCTS) Reports 149% Revenue Growth, 5G Ramp Extends to H1 2027
Q3 revenue increased approximately 149% year over year; the release provides no absolute revenue figure. GCT expects its 5G shipment ramp to extend into the first half of 2027 as customers take longer than expected to im
EARNINGS | Nov 12, 2026, 09:05 PM UTC
L
ONCE UPON A FARM PBC Q3 ADJUSTED EBITDA USD -1 MILLION
ONCE UPON A FARM PBC Q3 ADJUSTED EBITDA USD -1 MILLION
FX | Nov 12, 2026, 09:05 PM UTC